Arbel Medical Unveils Innovative APOC(TM) Cryosurgical Technology; Developer of Next-Generation Cryosurgical Solutions to Present Affordable, Office-Oriented, Adjustable Cryogen Pulse Solutions at Medtech InSight In3 Europe 2006 Conference.YOKNEAM, Israel -- Arbel Medical Ltd., a developer of advanced medical devices focused on minimally invasive technologies for tissue and tumor ablation, today announced it will be presenting its innovative APOC APOC As Per Our Conversation APOC Apocalypse APOC Apocrypha APOC Anarchist People of Color APOC Asia-Pacific Optical and Wireless Communications Conference APOC Association of Postal Officials of Canada (TM) technology at Medtech Insight's "Investment in Innovation (In3) Europe: A Preview of Early-Stage Medical Technology Companies" conference, to be held September 18-20, 2006, at the Crowne Plaza Brussels City Centre Hotel in Brussels, Belgium. APOC, which stands for Adjustable Pulses of Cryogen cry·o·gen n. A liquid, such as liquid nitrogen, that boils at a temperature below about 110 Kelvin (-160°C) and is used to obtain very low temperatures; a refrigerant. , represents a significant step forward in the field of cryosurgery cryosurgery (krī`ōsr'jərē), bloodless surgical technique using a supercooled probe to destroy diseased or superfluous tissue. . The technology facilitates the development of affordable systems enabling cryoprobe cryoprobe /cryo·probe/ (kri´o-prob) an instrument for applying extreme cold to tissue. cry·o·probe n. A surgical instrument used to apply extreme cold to tissues during cryosurgery. or flexible cryocatheter with high freezing capacity and low operating pressure. Arbel Medical's first APOC-based platform, which enables general cryosurgery procedures to be performed in a low-cost, patient-friendly office setting, places preliminary focus on breast care and dermatology applications and will be available for clinical testing in early 2007. "APOC is a breakthrough technological platform representing the third generation of cryosurgical systems," explained Didier Toubia, Arbel Medical's Chief Executive Officer. "It is a highly effective alternative to current standard lumpectomy Lumpectomy Definition A lumpectomy is a type of surgery used to treat breast cancer. It is considered "breast-conserving" surgery because in a lumpectomy, only the malignant tumor and a surrounding margin of normal breast tissue are or partial mastectomy mastectomy (măstĕk`təmē), surgical removal of breast tissue, usually done as treatment for breast cancer. There are many types of mastectomy. In general, the farther the cancer has spread, the more tissue is taken. treatments, which require the use of operating rooms and involve sedation, scarring, and 2 to 3 days of post-op recovery." Toubia added: "Arbel Medical plans to leverage its patented APOC core technology to address an ever-growing range of medical applications in office-based environments. Our vision is to reduce health care costs by as much as 40-50%, while improving patient care and compliance in comparison to existing treatment options." About Arbel Medical Ltd. Arbel Medical is a private, VC-backed developer of innovative, minimally invasive cryotherapy Cryotherapy Definition Cryotherapy is a technique that uses an extremely cold liquid or instrument to freeze and destroy abnormal skin cells that require removal. and cryosurgery ablation devices, with a preliminary focus on benign tumor benign tumor n. A tumor that does not metastasize or invade and destroy adjacent normal tissue. Benign tumor An abnormal proliferation of cells that does not spread to other parts of the body. and tissue ablation. The company's office-oriented devices are based on unique cryosurgery technology, which offers such benefits as safe and reliable treatment and reduction of surgical and hospitalization costs. For more information, please visit www.arbel-medical.com. About Medtech Insight's Investment in Innovation (In3) Europe Conference Medtech Insight's In3 conference highlights emerging technologies developed by more than 50 innovative start-up medical technology companies -- from both Europe and the U.S. -- seeking strategic partners and/or investment. The conference is attended by hundreds of senior-level decision-makers from the investment community and from major medical technology, biopharmaceutical, biotech, and other companies. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion